State Street Corp Spring Works Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 3,090,552 shares of SWTX stock, worth $129 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,090,552

Previous 3,086,845 0.12%

Holding current value

$129 Million

Previous $116 Million 14.84%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$32.04 - $42.76 $118,772 - $158,511	3,707 Added 0.12%	3,090,552 $99 Million
Q2 2024 Aug 14, 2024	BUY	$36.06 - $47.62 $4.52 Million - $5.96 Million	125,221 Added 4.23%	3,086,845 $116 Million
Q1 2024 May 15, 2024	BUY	$36.5 - $52.5 $12.5 Million - $18 Million	341,974 Added 13.05%	2,961,624 $146 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $917,718 - $1.8 Million	48,454 Added 1.88%	2,619,650 $95.6 Million
Q3 2023 Nov 14, 2023	SELL	$23.12 - $31.38 $13.5 Million - $18.3 Million	-584,355 Reduced 18.52%	2,571,196 $59.4 Million
Q2 2023 Aug 14, 2023	BUY	$23.15 - $32.71 $7.97 Million - $11.3 Million	344,280 Added 12.25%	3,155,551 $82.7 Million
Q1 2023 May 15, 2023	SELL	$24.97 - $34.05 $23.6 Million - $32.2 Million	-944,418 Reduced 25.15%	2,811,271 $72.4 Million
Q4 2022 Feb 14, 2023	BUY	$21.73 - $28.72 $9.38 Million - $12.4 Million	431,627 Added 12.98%	3,755,689 $97.7 Million
Q3 2022 Nov 15, 2022	SELL	$24.1 - $39.66 $13.6 Million - $22.4 Million	-565,187 Reduced 14.53%	3,324,062 $94.8 Million
Q2 2022 Aug 15, 2022	BUY	$18.36 - $60.07 $42.1 Million - $138 Million	2,293,359 Added 143.7%	3,889,249 $95.8 Million
Q1 2022 May 16, 2022	BUY	$48.97 - $65.46 $13.6 Million - $18.1 Million	276,779 Added 20.98%	1,595,890 $90.1 Million
Q4 2021 Feb 14, 2022	SELL	$53.3 - $75.84 $549,363 - $781,682	-10,307 Reduced 0.78%	1,319,111 $81.8 Million
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $15.5 Million - $21.8 Million	247,497 Added 22.88%	1,329,418 $84.3 Million
Q2 2021 Aug 16, 2021	BUY	$67.45 - $85.63 $158,709 - $201,487	2,353 Added 0.22%	1,081,921 $89.2 Million
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $105,201 - $151,241	1,616 Added 0.15%	1,079,568 $79.4 Million
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $13.6 Million - $21.9 Million	281,110 Added 35.28%	1,077,952 $78.2 Million
Q3 2020 Nov 10, 2020	BUY	$36.14 - $51.99 $15.2 Million - $21.9 Million	421,306 Added 112.19%	796,842 $38 Million
Q2 2020 Aug 14, 2020	BUY	$22.98 - $48.57 $4.64 Million - $9.82 Million	202,117 Added 116.55%	375,536 $15.8 Million
Q1 2020 May 11, 2020	BUY	$20.44 - $41.21 $3.54 Million - $7.15 Million	173,419 New	173,419 $4.68 Million

Others Institutions Holding SWTX

# of Institutions

238

Shares Held

69.8M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.61B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Spring Works Therapeutics, Inc. Transaction History